Home » City bigwig AJ Bell launches investment app

City bigwig AJ Bell launches investment app

by LLT Editor
30th Nov 21 12:56 pm

AJ Bell is to launch a new, app-only investment platform which aims to make investing more straightforward and accessible for retail investors. The new service will be called Dodl by AJ Bell and will compete with the lowest cost investment platforms in the market, with an annual charge of 0.15% and no commission for buying/selling investments.

Dodl will be an easy to use, jargon free investment app to help people invest for their long-term goals.  It will offer an Individual Savings Account (ISA), Lifetime ISA, Pension and General Investment Account. Customers will be able to set up regular investments and consolidate existing ISAs and Pensions onto the platform.

People will be able to pay money in to accounts via Apple and Google pay, as well as debit card payments and direct debits. Investing needn’t be scary, with Dodl’s friendly monster characters (see attached images) on hand to guide people through the application process, as well as providing information to help people make their investment decisions.

Dodl will give investors access to a simplified investment range with options to cater for the vast majority of investment risk appetites.

For those that like to invest in the brands they love, Dodl will feature a range of popular shares in UK listed companies, with US companies being added soon after launch.  In addition, there will also be a range of ‘themed investments’ which include funds focusing on core areas such as technology, robotics, healthcare and responsible investing.

The fund range will also consist of the AJ Bell’s low-cost multi-asset funds, which cater for six different risk levels along with AJ Bell’s Responsible Growth fund, for people who want to invest with a responsible focus.

The Dodl by AJ Bell mobile app will be a new platform for investors that sits alongside AJ Bell’s existing consumer platform AJ Bell Youinvest.

You may also like

Leave a Comment

CLOSE AD